AYTU

AYTU

USD

Aytu BioPharma Inc. Common Stock

$2.150+0.000 (0.000%)

Reaalajas hind

Healthcare
Drug Manufacturers - Specialty & Generic
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$2.150

Kõrge

$2.170

Madal

$2.100

Maht

0.10M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

19.3M

Tööstusharu

Drug Manufacturers - Specialty & Generic

Riik

United States

Kauplemisstatistika

Keskmine maht

1.48M

Börs

NCM

Valuuta

USD

52 nädala vahemik

Madal $0.95Praegune $2.150Kõrge $2.87

Seotud uudised

Analyst Upgrades

Ascendiant Capital Initiates Coverage On Aytu BioPharma with Buy Rating, Announces Price Target of $12

Ascendiant Capital analyst Edward Woo initiates coverage on Aytu BioPharma with a Buy rating and announces Price Target of $12.

Vaata rohkem
Ascendiant Capital Initiates Coverage On Aytu BioPharma with Buy Rating, Announces Price Target of $12
AccessWire

Aytu BioPharma Announces Closing of Upsized At the Market Public Offering of Common Stock with Full Exercise of Overallotment and Conference Call to Discuss First-in-Class Antidepressant EXXUA(TM) Opportunity and Commercialization Plan

Gross proceeds from offering total $16.6 million.Financing led by long-term, healthcare-focused institutional investors, including Aytu's largest shareholders Nantahala Capital Management and Stonepine Capital

Vaata rohkem
Aytu BioPharma Announces Closing of Upsized At the Market Public Offering of Common Stock with Full Exercise of Overallotment and Conference Call to Discuss First-in-Class Antidepressant EXXUA(TM) Opportunity and Commercialization Plan